⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL779806 | 0.81 | — | — | |
| SCHEMBL1036248 | 0.69 | — | — | |
| SCHEMBL10472341 | 0.59 | — | — | |
| SCHEMBL778160 | 0.58 | — | — | |
| SCHEMBL78894 | 0.58 | — | — | |
| SCHEMBL779921 | 0.58 | — | — | |
| SCHEMBL2014682 | 0.56 | — | — | |
| SCHEMBL2870637 | 0.56 | — | — | |
| SCHEMBL2869233 | 0.56 | — | — | |
| SCHEMBL7001374 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1083 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022129196-A1 | HETEROBICYCLE SUBSTITUTED 1,2,4-OXADIAZOLES AS FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-06-23 | — | — | WO | claimed |
| US-20220144815-A1 | 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-05-12 | — | — | US | claimed |
| WO-2021255091-A1 | 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-12-23 | — | — | WO | claimed |
| EP-3897154-A1 | 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS | Bayer Aktiengesellschaft (DE) | 2021-10-27 | — | — | EP | claimed |
| CN-113473860-A | 1, 3, 4-oxadiazoles and derivatives thereof as novel antifungal agents | 拜耳公司 | 2021-10-01 | — | — | CN | claimed |
| CN-109689660-B | 1,2, 4-triazolo- [3,4-b ] -1,3, 4-thiadiazole derivatives | 格林尼卡股份公司 | 2021-08-10 | — | — | CN | claimed |
| EP-3386511-B1 | METHODS FOR TREATING HUNTINGTON'S DISEASE | PTC THERAPEUTICS INC (US) | 2021-05-12 | — | — | EP | claimed |
| US-10874672-B2 | Methods for treating Huntington's disease | PTC THERAPEUTICS, INC. (US) | 2020-12-29 | — | — | US | claimed |
| WO-2020127974-A1 | 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-06-25 | — | — | WO | claimed |
| US-7268158-B2 | 6H-THIENO [2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH) | ASTRAZENECA AB (SE) | 2007-09-11 | — | — | US | claimed |
| US-7132442-B2 | 6H-thieno[2, 3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH) | ASTRAZENECA AB (SE) | 2006-11-07 | — | — | US | claimed |
| US-20060235067-A1 | 6H-THIENO[2,3-b]PYRROLE DERIVATIVES AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE (GNRH) | ASTRAZENECA AB (SE) | 2006-10-19 | — | — | US | claimed |
| US-20240239790-A1 | 7-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor | LIFEARC (GB) | 2024-07-18 | — | — | US | disclosed |
| WO-2024149990-A1 | NIRMATRELVIR ANALOGS AS 3C LIKE PROTEASE INHIBITORS FOR TREATING VIRAL INFECTIONS | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2024-07-18 | — | — | WO | disclosed |
| CN-112469716-B | Dihydropyrimidine derivatives and uses thereof | 深圳扬厉医药技术有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118355016-A | SOS1 inhibitors | 北京望实智慧科技有限公司 | 2024-07-16 | — | — | CN | disclosed |
| US-4274837-A | HYDROCARBLY-POLYOXYALKYLENE-AMINOCARBAMATES | CHEVRON RESEARCH COMPANY (US) | 1981-06-23 | — | — | US | disclosed |
| US-4233168-A | POLYOXYALKYLENE AMINOCARBAMATES | CHEVRON RESEARCH COMPANY (US) | 1980-11-11 | — | — | US | disclosed |
| US-4197409-A | ANTIDEPOSITE FUEL ADDITIVES OR OIL ADDITIVES | CHEVRON RESEARCH COMPANY (US) | 1980-04-08 | — | — | US | disclosed |
| US-4191537-A | ANTIDEPOSIT AGENTS | CHEVRON RESEARCH COMPANY (US) | 1980-03-04 | — | — | US | disclosed |